Clinicians should provide a second dose of 2024-2025 COVID-19 vaccine, at least 6 months after the first dose, to adults 65 and older and people 6 months and older with moderate or severely weakened immune systems.
The current dengue outbreak in Puerto Rico has resulted in higher rates of hospitalizations than previous outbreaks, with more than half of patients needing hospital care.
CDC updated recommendations for the MenB-4C (Bexsero) dosing interval and schedule to align with the new FDA label for this serogroup B meningococcal vaccine.
A new, free CE from MMWR and Medscape discusses updated recommendations on the prevention and control of seasonal influenza from the Advisory Committee on Immunization Practices.
The latest MMWR Weekly Briefing is live. Topics include: the spread of human parvovirus B19 in the United States; emergency department visits for firearm injuries, and more. Listen and subscribe on: Apple Podcasts and Spotify.
